Dabur India posts 15% profit jump in Q1 FY27, reaffirms double-digit growth target
Dabur India delivered strong Q1 FY27 results with a 15% jump in net profit to ₹591 crore and 10.6% revenue growth to ₹3,764 crore. EBITDA margin remained stable at 19.69%. The company highlighted robust performance in HPC and international markets, alongside a strategic focus on acquisitions and capital efficiency.

*this image is generated using AI for illustrative purposes only.
Dabur India Limited reported a 15% year-on-year increase in consolidated net profit to ₹591 crore for the quarter ended June 30, 2026, surpassing analyst estimates of ₹5.73 billion. Consolidated revenue from operations rose 10.6% to ₹3,764 crore, while EBITDA stood at ₹7.41 billion against an estimate of ₹7.42 billion. The EBITDA margin remained stable at 19.69%, slightly above the year-ago level of 19.6%. Global CEO Mohit Malhotra attributed the robust performance to broad-based growth across domestic and international businesses, despite inflationary headwinds and geopolitical disruptions in the Middle East affecting input costs.
The Board of Directors approved the unaudited financial results on July 29, 2026. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript of the subsequent investors’ conference call was submitted to BSE and NSE on August 03, 2026, signed by Group Company Secretary and Chief Compliance Officer Ashok Kumar Jain.
Key Financial Highlights
The following table summarises Dabur India's key consolidated financial metrics for Q1 FY27:
| Metric: | Q1 FY27 | Q1 FY26 | Y-o-Y Growth | Estimate |
|---|---|---|---|---|
| Consolidated Revenue: | ₹3,764 crore | ₹3,404.60 crore | 10.60% | ₹37.7b |
| EBITDA: | ₹7.41b | ₹6.70b | — | ₹7.42b |
| EBITDA Margin: | 19.69% | 19.60% | +9 bps | 19.70% |
| Operating Profit: | ₹741.40 crore | ₹667.80 crore | 11.00% | — |
| Net Profit (PAT): | ₹591 crore | ₹513.90 crore | 15.00% | ₹5.73b |
On a standalone basis, revenue from operations increased 8.8% to ₹2,687.30 crore, with net profit rising 11% to ₹452.40 crore. Standalone operating margin expanded by 30 basis points to 19.9%. Material costs rose 9.9% to ₹1,982.00 crore, indicating effective cost containment measures.
Segment-Wise Performance
Home & Personal Care (HPC) led growth with a 12.3% rise. The hair oil portfolio grew approximately 18% overall, with 8% volume growth and the remainder driven by price increases linked to crude-linked inflation. Vatika launched the Bio-Infusions range, India's first no-added salt shampoo. Oral care saw near double-digit growth, with the herbal segment outperforming non-herbal by 550 basis points. In Healthcare, Honey grew in high single digits, gaining 150 basis points in market share, while Honitus registered 25% growth. The nutraceutical brand Siens grew 3x, with management targeting an annualised revenue run rate exit of approximately ₹50 crore for the brand by year-end.
International Operations and Regional Dynamics
International business contributed ₹1,006 crore, representing 27% of consolidated revenue, and grew 15.5% in INR terms. Key market growth rates included:
| Market / Region: | Growth |
|---|---|
| Bangladesh: | 34.30% |
| Nigeria: | 35.10% |
| Sub-Saharan Africa: | 28.00% |
| Egypt: | 28.40% |
| Turkey: | 26.90% |
| UK / European Union: | 21.90% |
| MENA Region (overall): | ~9% |
Global CEO Mohit Malhotra noted that dollar-denominated Middle East markets provide a currency tailwind for India-reported numbers, although war-related disruptions impacted broader MENA growth.
Capital Allocation and Outlook
Chief Financial Officer Ankush Jain disclosed that the company holds approximately ₹9,000 crore in net cash and investments, with roughly ₹6,500 crore located in India. The capital allocation framework prioritises four areas:
| Priority: | Details |
|---|---|
| Acquisitions: | ₹500 crore earmarked for Dabur Ventures; targeting 1–2 sizable acquisitions over 3 years |
| Dividend: | 100% of India profits returned as dividend |
| Capex – Greenfield: | New facility in Tamil Nadu; ₹400–₹500 crore allocated globally |
| International Expansion: | Residual overseas cash retained for international business growth |
Management is currently in discussions with two to three potential acquisition targets. Mohit Malhotra reaffirmed the company’s target of double-digit consolidated revenue growth for the full year, driven by a combination of price and volume, while cautioning that volume growth may remain under pressure due to elevated inflation.
Historical Stock Returns for Dabur India
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.51% | -1.68% | -6.49% | -22.53% | -22.74% | -34.67% |
How might the company's strategy of retaining residual overseas cash impact its ability to navigate future currency volatility in key international markets like Nigeria and Bangladesh?
Given the target of 1-2 sizable acquisitions over three years, what specific criteria will Dabur Ventures use to evaluate potential targets in the nutraceutical or personal care sectors?
Will Dabur consider passing on further crude-linked inflation costs to consumers in the hair oil segment, and how might this affect volume growth in price-sensitive markets?


































